يعرض 1 - 20 نتائج من 56,095 نتيجة بحث عن '"ANDROGENS"', وقت الاستعلام: 0.65s تنقيح النتائج
  1. 1
    Dissertation/ Thesis

    المؤلفون: Monserrat Vicente, Laia

    المساهمون: University/Department: Universitat de Barcelona. Facultat de Medicina i Ciències de la Salut

    Thesis Advisors: Serra Elizalde, Violeta, Bellet Ezquerra, Meritxell, Agell i Jané, Neus

    المصدر: TDX (Tesis Doctorals en Xarxa)

    وصف الملف: application/pdf

  2. 2
    Dissertation/ Thesis

    المؤلفون: Alegre Martí, Andrea

    المساهمون: University/Department: Universitat de Barcelona. Facultat de Farmàcia i Ciències de l'Alimentació

    Thesis Advisors: Estébanez Perpiñá, Eva, Fuentes Prior, Pablo

    المصدر: TDX (Tesis Doctorals en Xarxa)

    وصف الملف: application/pdf

  3. 3
    Academic Journal
  4. 4
    Academic Journal

    المؤلفون: Wolken, Jill K.1 (AUTHOR), Peterson, Meghan M.1 (AUTHOR), Cao, Wenjing1,2 (AUTHOR), Challoner, Keith1 (AUTHOR), Jin, Zhicheng1,2 (AUTHOR) zjin237@wisc.edu

    المصدر: Journal of Clinical Medicine. Dec2024, Vol. 13 Issue 23, p7056. 9p.

  5. 5
    Academic Journal

    المؤلفون: Yamaguchi-Tanaka, Mio1,2 (AUTHOR) takashi.suzuki.c1@tohoku.ac.jp, Takagi, Kiyoshi2 (AUTHOR) kiyoshi.takagi.b7@tohoku.ac.jp, Sato, Ai2 (AUTHOR), Yamazaki, Yuto3 (AUTHOR), Miyashita, Minoru4 (AUTHOR), Masamune, Atsushi1,5 (AUTHOR), Suzuki, Takashi2,3,6 (AUTHOR)

    المصدر: Cancers. Dec2024, Vol. 16 Issue 23, p4043. 17p.

  6. 6
    Academic Journal
  7. 7
  8. 8
    Academic Journal
  9. 9
    Academic Journal

    المؤلفون: Hackney, Anthony C.1 (AUTHOR) ach@email.unc.edu, Prado, Raul Cosme Ramos2 (AUTHOR), Dolan, Eimear3 (AUTHOR)

    المصدر: Endocrines. Sep2024, Vol. 5 Issue 3, p252-260. 9p.

  10. 10
    Academic Journal
  11. 11
    Dissertation/ Thesis

    المؤلفون: Frigolé Vivas, Marta

    المساهمون: University/Department: Universitat de Barcelona. Facultat de Química

    Thesis Advisors: Riera i Escalé, Antoni, Salvatella i Giralt, Xavier

    المصدر: TDX (Tesis Doctorals en Xarxa)

    وصف الملف: application/pdf

  12. 12
    Report

    المصدر: The Registry to Observe Clinical Outcomes of Patients With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan

  13. 13
    Report

    المؤلفون: Varian Medical Systems

    المصدر: Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer

  14. 14
    Report
  15. 15
    Report

    المؤلفون: Bristol-Myers Squibb

    المساهمون: Xiao X. Wei, MD, Sponsor Investigator

    المصدر: A Phase 2 Multicohort Study of Nivolumab in Combination with Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone Sensitive Prostate Cancer Patients with DNA Damage Repair Defects or Inflamed Tumors

  16. 16
    Report

    المصدر: China ARCHES: A Multicenter, Phase 3, Randomized, Double-blind, Placebo Controlled Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

  17. 17
    Report

    المؤلفون: AstraZeneca

    المساهمون: Abdenour Nabid, Principal Investigator

    المصدر: Randomized, Multicentre, Phase III Study in Patients with Intermediate-risk T1 T2 Prostate Adenocarcinomas, to Verify the Role of Six Months of Total Androgen Blockade for Two Dosage Levels of Prostate Radiation Therapy (70 Gy and 76 Gy) Versus Prostate Radiation Therapy Alone At 76 Gy
    Nabid A, Carrier N, Vigneault E, Van Nguyen T, Vavassis P, Brassard MA, Bahoric B, Archambault R, Vincent F, Bettahar R, Wilke D, Souhami L. Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial. Eur J Cancer. 2021 Jan;143:64-74. doi: 10.1016/j.ejca.2020.10.023. Epub 2020 Dec 3.

  18. 18
    Report

    المؤلفون: AstraZeneca

    المساهمون: Abdenour Nabid, Principal Investigator

    المصدر: Randomized, Multicentre, Phase III Study: Assessment of the Duration of Androgen Blockade Combined with Pelvic Irradiation in High-risk Prostate Cancers

  19. 19
    Report

    المصدر: A Multicenter Phase 4, Open-label, Single-arm, Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy

  20. 20
    Report

    المصدر: A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Darolutamide in Addition to Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Men With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)